- Investing Ideas
- /
- Global Undervalued Solid Performers
Global Undervalued Solid Performers
UPDATED Jun 01, 2024
Companies meeting several financial criteria and filtered from the entire market.
276 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GOOGL | US$172.50 | -1.4% | 38.4% | US$2.1t | US$193.29 | PE25.9x | E11.6% | 0.5% | Media | ||
2330 | NT$821.00 | -5.3% | 46.1% | NT$21.3t | NT$929.18 | PE24.8x | E16.4% | 1.9% | Semiconductors | ||
600519 | CN¥1,648.45 | -1.7% | -1.3% | CN¥2.1t | CN¥2,160.04 | PE26.5x | E12.7% | 3.0% | Food, Beverage & Tobacco | ||
CRM | US$234.44 | -13.9% | 10.1% | US$227.2b | US$302.04 | PE41.5x | E14.1% | 0.7% | Software | ||
ADBE | US$444.76 | -6.5% | 1.9% | US$199.3b | US$614.33 | PE41.5x | E17.1% | n/a | Software | ||
INTU | US$576.44 | -5.0% | 33.9% | US$161.1b | US$693.38 | PE52.5x | E16.0% | 0.6% | Software | ||
CDI | €702.00 | -1.4% | -11.4% | €126.6b | n/a | PE20.1x | n/a | 1.9% | Consumer Durables | ||
VRTX | US$455.34 | -0.4% | 36.4% | US$117.5b | US$463.53 | PE29.2x | E10.4% | n/a | Pharmaceuticals & Biotech | ||
CB | US$270.82 | 2.3% | 40.8% | US$113.6b | US$269.50 | PE12.2x | E0.7% | 1.3% | Insurance | ||
1088 | HK$37.95 | 4.7% | 49.4% | HK$882.0b | HK$33.13 | PE12.3x | E1.0% | 6.4% | Energy | ||
REGN | US$980.16 | -0.5% | 32.5% | US$105.7b | US$1,041.93 | PE27.4x | E12.5% | n/a | Pharmaceuticals & Biotech | ||
858 | CN¥146.70 | -2.9% | -12.6% | CN¥569.4b | CN¥191.22 | PE18x | E10.7% | 3.2% | Food, Beverage & Tobacco | ||
MRK | €166.50 | -0.7% | -0.4% | €72.4b | €184.81 | PE26.6x | E11.8% | 1.3% | Pharmaceuticals & Biotech | ||
8766 | JP¥5,429.00 | 5.2% | 71.4% | JP¥10.6t | JP¥4,795.45 | PE15.3x | E3.3% | 2.9% | Insurance | ||
MUV2 | €457.90 | -0.9% | 33.7% | €61.1b | €473.52 | PE11.2x | E2.9% | 3.3% | Insurance | ||
NTES | US$89.03 | -1.6% | 2.8% | US$57.4b | US$129.56 | PE13.7x | E7.6% | 2.9% | Media | ||
MRNA | US$142.55 | -14.4% | 9.2% | US$54.6b | US$139.95 | PS10.6x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
300760 | CN¥290.14 | -4.0% | -3.8% | CN¥350.9b | CN¥393.76 | PE28.8x | E15.1% | 2.0% | Healthcare | ||
LEN | US$160.35 | 2.5% | 43.2% | US$44.2b | US$178.05 | PE11.1x | E4.1% | 1.2% | Consumer Durables | ||
PAYX | US$120.16 | -3.3% | 9.0% | US$43.3b | US$120.87 | PE26x | E6.3% | 3.3% | Commercial Services | ||
LONN | CHF486.40 | -5.6% | -17.1% | CHF35.1b | CHF576.86 | PE53.6x | E20.7% | 0.8% | Pharmaceuticals & Biotech | ||
ACGL | US$102.63 | -0.7% | 44.8% | US$38.4b | US$108.20 | PE8x | E-11.4% | n/a | Insurance | ||
DDOG | US$110.18 | -10.9% | 11.6% | US$36.9b | US$146.34 | PE319.7x | E24.1% | n/a | Software | ||
DB1 | €182.90 | -0.8% | 10.4% | €33.9b | €204.56 | PE19.4x | E5.7% | 2.1% | Diversified Financials |